fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Co-users of tobacco and cannabis risk more anxiety and depression than non-users

Written by | 14 Sep 2023

Co-users of tobacco and cannabis report more anxiety and depression than users of tobacco only and users of neither substance. Researchers reported these findings in PLOS ONE on… read more.

Exercise apps a good prescription to boost healthcare workers’ mental health

Written by | 4 Sep 2023

Simple home workouts using exercise apps can effectively reduce depressive symptoms in healthcare workers and could be a major tool to combat the global mental health crisis in… read more.

New blood test gives very high accuracy to screen for Alzheimer’s disease

Written by | 2 Sep 2023

A new blood test called p-tau217 shows promise as an Alzheimer’s disease biomarker, and when used in a two-step workflow very high accuracy to either identify or exclude… read more.

Why breast cancer survivors don’t take their medication, and what can be done

Written by | 1 Sep 2023

For roughly 80% of breast cancer survivors, treatment doesn’t end with surgery, radiation and chemotherapy. Instead, for the next five to 10 years, doctors recommend that they take… read more.

People who are in good shape take fewer mental-health related medication

Written by | 1 Sep 2023

“We find that people who are in better shape fill fewer prescriptions for anxiety and depression medications,” says Linda Ernstsen, the senior author of the article and an… read more.

Increased risk of dementia diagnosis, benzodiazepine exposure in seniors with anxiety

Written by | 11 Aug 2023

Research from Saint Louis University School of Medicine finds that among patients 65 and older, a diagnosis of anxiety was significantly associated with an increased risk of dementia… read more.

FDA approves Zurzuvae, the first and only oral treatment for postpartum depression, and issues a complete response letter for major depressive disorder – Sage Therapeutics + Biogen

Written by | 9 Aug 2023

Sage Therapeutics, Inc .and Biogen Inc. announced the FDA approved Zurzuvae (zuranolone) 50 mg for adults with postpartum depression (PPD). Zurzuvae is the first and only oral, once-daily,… read more.

Study finds ‘startling’ levels of hidden mental health symptoms among people living with long term autoimmune diseases

Written by | 27 Jul 2023

More than half of patients with auto-immune conditions experience mental health conditions such as depression or anxiety, yet the majority are rarely or never asked in clinic about… read more.

New talking therapy for depression could be more effective and cheaper than CBT

Written by | 23 Jul 2023

A new talking therapy for depression has shown encouraging early signs of being more effective and cheaper to deliver than the current best practice of Cognitive Behavioural Therapy… read more.

New research addresses mental health crisis in the construction industry

Written by | 20 Jul 2023

New research is tackling the mental health crisis in the construction industry – highlighting the benefits of an on-site Health Hub on worker wellbeing. The construction industry has… read more.

Depressed patients less likely to take their heart medications

Written by | 15 Jul 2023

Patients who feel low when having a cardiac device implanted are more likely to stop taking their heart medications than those without depression, according to research presented today… read more.

Fewer teens now perceive themselves as overweight – international study of more than 745,000 adolescents

Written by | 11 Jul 2023

A study involving more than 745,000 adolescents from 41 countries across Europe and North America identified an increase in the amount of teenagers who underestimate their body weight…. read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.